Discover 3,507 paid clinical trials in Santa Monica, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,507
Active & Responsive
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Santa Monica CA, Garden Grove CA, La Jolla CA,
Sponsor: Reunion Neuroscience Inc
Sex: All
Age: 18 - 70+
Code: NCT07489651
Phase 2, Recruiting
Active & Responsive
Pembrolizumab and Pemetrexed for Progressive Chordoma
for
Chordomas, Chordoma
Location: Santa Monica CA
Sponsor: Saint John's Cancer Institute
Sex: All
Age: 18+
Code: NCT06794645
Phase 2, Recruiting
Active & Responsive
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
for
Breast Neoplasms, Breast Cancer
Location: Santa Monica CA, Happy Valley OR, Billings MT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06797635
Phase 2, Recruiting
Active & Responsive
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-Resistant Prostate Cancer
Location: Los Angeles CA, Whittier CA, San Francisco CA,
Sponsor: Zenith Epigenetics
Sex: Male
Age: 18+
Code: NCT04986423
Phase 2, Recruiting
Active & Responsive
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
for
Breast Neoplasms, Brain Neoplasms, Neoplasms by Site, Neoplasms,
Location: Los Angeles CA, Fullerton CA, Houston TX, Urbana IL,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05386108
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
for
Degenerative Disc Disease
Location: Santa Monica CA, Thousand Oaks CA, Phoenix AZ,
Sponsor: DiscGenics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07254806
Phase 3, Recruiting
Active & Responsive
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
for
Knee Cartilage Defects
Location: Santa Monica CA, Encinitas CA, La Jolla CA, La Mesa CA,
Sponsor: Medipost, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07339111
Phase 3, Recruiting
Active & Responsive
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
for
Lumbar Disc Disease
Location: Santa Monica CA, Walnut Creek CA, Greenwood Village CO,
Sponsor: BioRestorative Therapies
Sex: All
Age: 18+
Code: NCT04042844
Phase 2, Recruiting
Active & Responsive
FOG-001 in Locally Advanced or Metastatic Solid Tumors
for
Cancer, Colorectal Cancer, Solid Tumor,
Location: Santa Monica CA, Los Angeles CA, Palo Alto CA,
Sponsor: Parabilis Medicines, Inc.
Sex: All
Age: 18+
Code: NCT05919264
Phase 1, Phase 2, Recruiting
Active & Responsive
Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid Tumors
for
Solid Tumor Cancer
Location: Santa Monica CA
Sponsor: Sarcoma Oncology Research Center, LLC
Sex: All
Age: 18+
Code: NCT07671534
Phase 2, Recruiting
Active & Responsive
Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.
for
Phantom Limb Syndrome With Pain
Location: Santa Monica CA, San Anselmo CA, Sacramento CA,
Sponsor: The Ketamine Research Foundation
Sex: All
Age: 18 - 65
Code: NCT07276542
Phase 2, Phase 3, Recruiting
Active & Responsive
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
for
EDS, Cataplexy, Fatigue, Narcolepsy
Location: Los Angeles CA, Lancaster CA, Redwood City CA,
Sponsor: Harmony Biosciences Management, Inc.
Sex: All
Age: 18+
Code: NCT07675135
Phase 3, Recruiting
Active & Responsive
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
for
Idiopathic Hypersomnia
Location: Santa Monica CA, Morrisville NC, Lancaster CA,
Sponsor: Harmony Biosciences Management, Inc.
Sex: All
Age: 18+
Code: NCT07500090
Phase 3, Recruiting
Active & Responsive
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
for
Triple Negative Breast Cancer (TNBC)
Location: Los Angeles CA, San Antonio TX, Nashville TN,
Sponsor: Immunomic Therapeutics, Inc.
Sex: Female
Age: 18+
Code: NCT07652242
Phase 1, Recruiting
Active & Responsive
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Los Angeles CA, Beverly Hills CA, Orange CA, Irvine CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05136196
Phase 2, Recruiting
Active & Responsive
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
Location: Los Angeles CA, Beverly Hills CA, Woodland Hills CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07441681
Phase 3, Recruiting
Active & Responsive
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Los Angeles CA, Cerritos CA, Bakersfield CA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT06901531
Phase 3, Recruiting
Active & Responsive
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Los Angeles CA, San Francisco CA, Aurora CO,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 12+
Code: NCT05533697
Phase 1, Phase 2, Recruiting
Active & Responsive
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma